Stem cell-derived islet therapy: is this the end of the beginning?

Competing interests

M.H. holds stocks in Encellin Inc. and Thymmune Therapeutics Inc. M.H. consults for CV Next and holds stock in the latter. M.H. is the co-founder and SAB member of Minutia Inc. and holds stocks and options in the company. V.A.C. declares no competing interests.

留言 (0)

沒有登入
gif